25% of Pediatric Chronic Dialysis Patients Readmitted Within 30 Days

One in four admissions for pediatric chronic dialysis results in a readmission within 30 days of discharge, according to a study in Clinical Journal of the American Society of Nephrology.

Advertisement

Researchers analyzed data from the Pediatric Hospital Information System on chronic dialysis patients between the ages of 3 months and 17 years from January 2006 to November 2010.

They found 25 percent of hospital admissions for these patients resulted in a readmission within 30 days.

Additionally, patients under 2 years old had higher odds of readmission (0.8 to 0.5). Patients receiving dialysis also had higher odds of readmission (1.4 to 1.0), as did admissions lasting more than 14 days (2.0 to 1.1).

Study authors suggest further research is necessary to reduce the high readmission rates for pediatric chronic dialysis patients.

More Articles on Readmission:

30-Day Readmission Linked to Higher Mortality for Glioblastoma Patients
Study: 15% of Avoidable Readmissions Linked to End-of-Life Care Issues
Readmission Rates Constant for Different Prostate Surgery Techniques

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Patient Safety & Outcomes

Advertisement

Comments are closed.